Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501319 · ClinicalTrials.gov registry record
Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 127
- Enrollment target
NCT00501319: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00501319 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00501319 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
Primary Objectives: * To longitudinally assess the natural history of symptoms (prevalence, severity, patterns of symptoms, and the relationship of physical and psychological distress) among post-thoracic surgery for non-small cell lung cancer patients with early stage (stage I-IIIA) disease. * To determine crisis events (when symptoms are most severe), their relationship with cancer therapy, surgical techniques and disease, and their relationship with function and quality of life; and to determine current practice patterns of symptom control throughout the six months of the post-surgical phase. * To determine the utility of a weekly, telephone-administered interactive voice response symptom assessment (IVR-MDASI) for identifying emergent clinically significant symptoms in this population. * To develop symptom severity critical values and critical treatment algorithms for post-operative symptom control for NSCLC patients.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interactive Voice Response (IVR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2003-04 |
| Est. Completion | 2011-10 |
What the finished NCT00501319 record still lists
NCT00501319 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00501319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00501319 about?
NCT00501319 is a clinical study titled "Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery". Primary Objectives: * To longitudinally assess the natural history of symptoms (prevalence, severity, patterns of symptoms, and the relationship of physical and psychological distress) among post-thoracic surgery for non-small cell lung cancer patients with early stage (stage I-IIIA) disease. * To ...
What is the current status of trial NCT00501319?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2003-04. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00501319?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interactive Voice Response (IVR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00501319?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia